Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Funke, G. Articles by Frodl, R. Search for Related Content PubMed PubMed Citation Articles by Funke, G. Articles by Frodl, R.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, March 2005, p. 1032-1036, Vol. 43, No. 3
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.3.1032-1036.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

First Description of Curtobacterium spp. Isolated from Human Clinical Specimens

Guido Funke,^1* Max Aravena-Roman,² and Reinhard Frodl¹

Department of Medical Microbiology and Hygiene, Gärtner & Colleagues Laboratories, Weingarten, Germany,¹ Department of Microbiology and Infectious Diseases, Western Australian Centre for Pathology and Medical Research, Nedlands, Australia²

Received 18 October 2004/ Returned for modification 17 November 2004/ Accepted 22 November 2004

Top Abstract Introduction Materials and Methods Results Discussion References

 
During a 4-year period, five strains (three of which were doubtless clinically significant) of yellow- or orange-pigmented, oxidative, slowly acid-producing coryneform bacteria were recovered from human clinical specimens in two reference laboratories or referred to them. The strains were motile, catalase positive, nitrate reductase negative, and urease negative, but strongly hydrolyzed esculin. In all reference and clinical strains described in the present study, anteisopentadecanoic (C_15:0ai) and anteisoheptadecanoic (C_17:0ai) acids represented more than 75% of all cellular fatty acids except in one clinical strain and in Curtobacterium pusillum, in which both the unusual -cyclohexyl fatty acid (identified as C_{18:17cis/9cis/12trans} by the Sherlock system) represented more than 50% of all cellular fatty acids. In all clinical strains, ornithine was the diamino acid of the cell wall, the interpeptide bridge consisted of ornithine, and acetyl was the acyl type of the peptidoglycan. Therefore, the five clinical strains were unambiguously identified as Curtobacterium spp. Analyses of the complete 16S rRNA genes of the five clinical strains with homologies to the established Curtobacterium species ranging from 99.2 to 100% confirmed the identifications as Curtobacterium spp. Data on the antimicrobial susceptibility pattern of curtobacteria are reported, with macrolides and rifampin showing very low MICs for all strains tested. This report is the first on the isolation of Curtobacterium strains from human clinical specimens.

Top Abstract Introduction Materials and Methods Results Discussion References

 
It is generally accepted that the identification of coryneform bacteria is one of the more difficult tasks for clinical microbiologists identifying microorganisms. This is mainly due to the enormous heterogeneity of these bacteria, presently comprising more than a dozen medically relevant genera with more than 100 species in total (5). Commercial identification systems do not cover the whole range of coryneform bacteria so that final identification is very often performed in a specialized laboratory. This report is on the identification of some rarely encountered oxidative, slowly acid-producing coryneform bacteria which were isolated at or received for identification by a reference laboratory in Europe and one in Australia.

Detailed phenotypic and chemotaxonomic investigations revealed that the five clinical strains included in this study belonged to the genus Curtobacterium. This genus had been defined by Yamada and Komagata in 1972 for some so-called motile brevibacteria. Curtobacterium strains had been isolated from rice and other plants and C. flaccumfaciens, in particular, is a well-established plant pathogen (2, 14). At present the genus Curtobacterium comprises six validated species (1, 14). However, curtobacteria have never been described as being isolated from humans.

This paper aims at outlining tests which may lead to the diagnosis of curtobacteria in a routine clinical laboratory. In addition, it adds further evidence that environmental coryneform bacteria might be transmitted to humans and cause disease as has been recently demonstrated for the genera Microbacterium/Aureobacterium, Cellulomonas, and Arthrobacter (6, 8, 10, 13).

Top Abstract Introduction Materials and Methods Results Discussion References

 
Strains, media, and growth conditions. Table 1 lists the reference strains used in the present study. During a 4-year period, the five clinical strains were isolated at or referred to the Department of Medical Microbiology and Hygiene, Gärtner & Colleagues Laboratories, Weingarten, Germany (strains 1594, 2340, and 2384), and the Department of Microbiology and Infectious Diseases, Western Australian Centre for Pathology and Medical Research, Nedlands, Australia (strains 3426 and 3430). All strains were subcultured on Columbia blood agar (BD, Heidelberg, Germany) at either 37°C or 30°C depending on the optimal growth temperature of the strains (see below).

View this table: [in this window] [in a new window]

TABLE 1. Strains included in the present study

Biochemical tests. Preparation of the media used for biochemical characterization of the strains studied was according to Nash and Krenz (15). Biochemical tests were performed at 30°C due to the fact that some strains had their optimal growth temperature at 30°C. Motility was observed by the hanging drop method by incubating cells in Trypticase soy broth (all media from BD, unless stated otherwise). Nitrate reduction was tested in nitrate broth, hydrolysis of urea was observed in Christensen's urea broth, and esculin hydrolysis was observed on modified esculin agar (9). Acid production from glucose, maltose, sucrose, mannitol, and xylose was observed in cystine Trypticase agar (CTA) medium containing 1% of the carbohydrates (Sigma Chemical Co., St. Louis, Mo.). The type of metabolism was observed by using CTA medium with acid production or alkalinization at the surface and no change at the bottom of the tube indicating an oxidative metabolism. Enzymatic activities were determined by means of the API ZYM system (bioMérieux, Marcy l'Etoile, France) by reading the strips after 4 h of incubation. Identification of the C. plantarum strain was achieved by using the commercial API 32E strip (bioMérieux).

Antimicrobial susceptibility patterns. The MICs of 38 antimicrobial agents were determined by using the MCN microdilution system (Merlin Diagnostics, Bornheim-Hersel, Germany) combined with H-medium (Merlin) as described previously (4).

Chemotaxonomic investigations. For analysis of cellular fatty acid patterns, cells were processed as described previously (19), and gas-liquid chromatography was performed on the Sherlock system (Microbial ID, Ind., Newark, Del.). The diamino acid of the total cell walls was determined by the method described previously (9). Analysis of the partial peptidoglycan structures was performed by the methods given by Schleifer and Kandler (16), except that ascending thin-layer chromatography on cellulose sheets (Merck, Darmstadt, Germany) was used. The determination of the acyl type of the peptidoglycan was according to Uchida and Aida (18).

16S rRNA gene sequencing and phylogenetic analysis. A detailed description of the technique applied for 16S rRNA gene sequencing is given in a recent report (7). The purified PCR products were sequenced in both directions and the resulting sequences were deposited in the GenBank-EMBL database. The sequences were compared with all of the eubacterial 16S rRNA gene sequences available in the GenBank-EMBL database by using the BLAST software tool from the National Center for Biotechnology Information (Bethesda, Md.).

Nucleotide sequence accession numbers. The 16S rRNA gene sequences of isolates 1594, 2340, 2384, 3426, and 3430 have been deposited in the EMBL/GenBank database under accession numbers AY688357, AY688358, AY688359, AY688360, and AY688361, respectively.

Top Abstract Introduction Materials and Methods Results Discussion References

 
The clinical strains 2384, 3426, and 3430 grew heavily in pure culture and a moderate leukocyte reaction was observed in direct Gram stains of the clinical material suggesting a disease association in these three cases. For strains 1594 and 2340, a disease association was not so clear as these two strains were grown in mixed culture although they had been the predominant microorganisms.

All 15 strains studied grew as nonhemolytic, creamy, yellow- or orange-pigmented colonies of about 1 to 1.5 mm in diameter after 24 to 48 h of incubation. Colonies of C. pusillum tended to exhibit glistening and mucoid colonies whereas colonies of C. plantarum were significantly larger (>2 mm) than the colonies of all other strains. C. albidum, C. flaccumfaciens (all four pathovars except pathovar flaccumfaciens), C. herbarum, as well as strains 2340 and 2384 showed better growth at 30°C than at 37°C whereas similar growth at 30°C and at 37°C was observed for C. citreum, C. luteum, C. plantarum, C. pusillum, and strains 1594, 3426, and 3430. However, all strains included in the present study were able to grow at 37°C.

Gram stains of all strains showed relatively small coryneform bacteria (curtus, shortened) except for the C. plantarum strain which was a gram-negative rod. Most strains were motile and exhibited an oxidative metabolism except C. plantarum which was fermentative. Because of the discrepant results of the Gram stain and the oxidation/fermentation test of the C. plantarum type strain further biochemical identification was performed and resulted in the identification of this particular strain as Pantoea sp. Hence this strain was excluded from further analyses.

The remaining 14 strains were all catalase positive, did not reduce nitrate, exhibited no urease activity, but all very strongly hydrolyzed esculin. Acid was produced within 4 days from glucose by all strains except C. citreum and C. pusillum. Acid production from maltose was positive for C. flaccumfaciens, C. herbarum, C. pusillum, as well as strains 2340, 2384, 3426, and 3430. Sucrose was not acidified by C. citreum, C. albidum, and C. pusillum but all other strains. Acid production from mannitol was positive for C. flaccumfaciens pathovar flaccumfaciens, C. flaccumfaciens pathovar poinsettiae, C. herbarum, and strains 3426 and 3430 whereas xylose was acidified by all strains included in the present study. It is emphasized that the acid production was only very weak in comparison to other oxidative coryneform bacteria. All strains exhibited activity of the following enzymes: esterase, esterase lipase, leucine arylamidase, acid phosphatase (except C. herbarum and strain 3426), -galactosidase (except C. pusillum and strains 2340 and 3430), ß-galactosidase, -glucosidase, ß-glucosidase, and -mannosidase. Activities of lipase (C₁₄), trypsin, and ß-glucuronidase were not detected in any of the strains tested.

Table 2 outlines the antimicrobial susceptibility patterns of the nine Curtobacterium reference strains and the five clinical isolates. The 50% and 90% MICs of ß-lactams were mostly greater than 1 µg/ml. Significantly, the MICs for macrolides (except azithromycin) and rifampin were 0.03 µg/ml for all strains tested. The MICs for amikacin and gentamicin were lower than for netilmicin and tobramycin as were the MICs for doxycycline and minocycline in comparison to tetracycline. The MICs of teicoplanin and vancomycin were lower than 2 µg/ml for every strain examined.

View this table: [in this window] [in a new window]

TABLE 2. MICs of antimicrobial agents against Curtobacterium strainsa

Cellular fatty acid analysis revealed that C_15:0ai and C_17:0ai presented more than 75% of all cellular fatty acids in every strain tested except two (Table 3). Much smaller amounts of C_15:0i, C_16:0i, and C_16:0 were also detected. The cellular fatty acid patterns of the strains studied were very similar with the exceptions of C. pusillum and strain 3430. For these particular two strains the Sherlock system named the major peak feature 7, consisting of C_{18:17cis/9cis/12trans} which could not be separated by the system.

View this table: [in this window] [in a new window]

TABLE 3. Cellular fatty acid profiles of Curtobacterium strains

Analysis of the peptidoglycan structure of the five clinical isolates demonstrated ornithine as the diamino acid and that the interpeptide bridge consisted of ornithine alone. The acyl type of the peptidoglycan was found to be acetyl. This combination of chemotaxonomic features is found in the genus Curtobacterium only (Table 4). Therefore, the five clinical isolates were unambiguously identified as Curtobacterium species.

View this table: [in this window] [in a new window]

TABLE 4. Differential diagnosis of Curtobacterium spp. from other medically relevant, yellow- or orange-pigmented coryneform bacteria other than Corynebacteriuma

The data of the 16S rRNA gene sequencing of the five clinical strains are given in Table 5. The homologies of the 16S rRNA genes between the clinical strains and their closest phylogenetic neighbors, curtobacteria, were always greater than 99.1%, unambiguously demonstrating that the strains are true members of the genus Curtobacterium. With no mismatches to C. flaccumfaciens, strains 2384 and 3426 are most likely representatives of this species.

View this table: [in this window] [in a new window]

TABLE 5. 16S rRNA gene data on the clinical strains included in the present study compared with the closest phylogenetic neighbor

Top Abstract Introduction Materials and Methods Results Discussion References

 
With a polyphasic approach the five clinical strains were identified as Curtobacterium species. Definitive identification on the species level was not attempted since the very few Curtobacterium strains described in the literature did not allow the creation of a reliable database for phenotypic differentiation on the species level.

Curtobacteria had never been described before as being recovered from human clinical specimens. Since curtobacteria have so far not been isolated from blood cultures or from other normally sterile body sites (except for strain 3430 in the present study) it is suggested that they act as colonizers rather than as invasive pathogens. In contrast, strains belonging to the species C. flaccumfaciens are well-established plant pathogens. For epidemiological purposes this species had been divided into four different pathovars whereas C. citreum, C. albidum, and C. luteum are not known to cause any disease on rice from which they were primarily isolated (14), and C. herbarum was isolated from grass (1). Other strains belonging to genera which are primarily associated with plants and can cause disease in those but may also colonize or infect humans include Pseudomonas, Stenotrophomonas, and Burkholderia.

Some curtobacteria with an optimal growth temperature of 30°C may not be isolated from human clinical specimens if the plates are routinely incubated at 37°C and read after 24 h only. Curtobacteria might be underdiagnosed because they are presently not included in the databases of commercial identification systems (11, 12) and chemotaxonomic investigations are necessary for complete identification of the organisms. However, it is the authors' experience that curtobacteria belong to the least frequently encountered yellow- or orange-pigmented coryneform bacteria (see Table 4) in clinical specimens. For example, the oxidative Microbacterium/Aureobacterium strains are 20 to 25 times more frequently detected in clinical specimens than curtobacteria (G. Funke, unpublished observation).

Apart from chemotaxonomic investigations simple biochemical tests like rapidity of acid production from carbohydrates (microbacteria usually within 2 days whereas in curtobacteria it may take up to 1 week or even longer) may serve in the identification of yellow- or orange-pigmented coryneform bacteria. In fact, an orange pigment in coryneform bacteria other than curtobacteria is rarely seen (e.g., M. arborescens, M. imperiale, M. schleiferi, and M. testaceum exhibit an orange pigment). It should also be noted that all curtobacteria tested until now are nitrate reductase and urease negative but strongly hydrolyze esculin (see Table 4).

C. pusillum is the only established Curtobacterium species which was not primarily isolated from plants. It is also very unusual in its characteristic that the majority of cellular fatty acids are identified as C_{18:17cis/9cis/12trans} by the Sherlock system and as -cyclohexyl undecanoic acid by another independent system (17). This discrepancy can be resolved by determining the precise cellular fatty acid structure by mass spectrometry. The authors are not aware of any gram-positive genus which includes both -cyclohexyl-containing and non--cyclohexyl-containing bacteria. Some -cyclohexyl-containing Bacillus species had recently been transferred into a separate genus, Alicyclobacillus (20).

C. plantarum (strain ATCC 49174) is certainly not a member of the genus Curtobacterium but a Pantoea strain. Since strain ATCC 49174 is the only strain that has ever been deposited (Phyllis Pienta, personal communication) the present paper raises the pursuit for a true C. plantarum strain as described by Dunleavy (3).

In summary, Curtobacterium strains are rarely isolated from clinical samples but clinical microbiologists should be aware of the possible appearance of these bacteria in material from humans although their pathogenicity is considered rather low since many people are probably exposed to curtobacteria every day. The tests outlined should facilitate the diagnosis of Curtobacterium spp. in the routine clinical laboratory. Finally, as with other recently described yellow-pigmented coryneform bacteria, it is expected that once a genus appears in the clinical microbiology literature, other workers will also find strains belonging to this particular genus in their specimens.

 
* Corresponding author. Mailing address: Department of Medical Microbiology and Hygiene, Gärtner & Colleagues Laboratories, Hoyerstrasse 51, D-88250 Weingarten, Germany. Phone: 49-751-502-630. Fax: 49-751-502-385. E-mail: ldg.funke{at}t-online.de.

Top Abstract Introduction Materials and Methods Results Discussion References

 

1
1. Behrendt, U., A. Ulrich, P. Schumann, D. Naumann, and K.-I. Suzuki. 2002. Diversity of grass-associated Microbacteriaceae isolated from the phyllosphere and litter layer after mulching the sward; polyphasic characterization of Subtercola pratensis sp. nov., Curtobacterium herbarum sp. nov. and Plantibacter flavus gen. nov., sp. nov. Int. J. Syst. Evol. Microbiol. 52:1441-1454.[Abstract]
2
2. Collins, M. D., and D. Jones. 1983. Reclassification of Corynebacterium flaccumfaciens, Corynebacterium betae, Corynebacterium oortii and Corynebacterium poinsettiae in the genus Curtobacterium, as Curtobacterium flaccumfaciens comb. nov. J. Gen. Microbiol. 129:3545-3548.
3
3. Dunleavy, J. M. 1989. Curtobacterium plantarum sp. nov. is ubiquitous in plant leaves and is seed transmitted in soybean and corn. Int. J. Syst. Bacteriol. 39:240-249.[Abstract/Free Full Text]
4
4. Funke, G., N. Alvarez, C. Pascual, E. Falsen, E. Akervall, L. Sabbe, L. Schouls, N. Weiss, and M. D. Collins. 1997. Actinomyces europaeus sp. nov., isolated from human clinical specimens. Int. J. Syst. Bacteriol. 47:687-692.[Abstract/Free Full Text]
5
5. Funke, G., and K. A. Bernard. 2003. Coryneform gram-positive rods, p. 472-501. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.), Manual of clinical microbiology, 8th ed. ASM Press, Washington, D.C.
6
6. Funke, G., E. Falsen, and C. Barreau. 1995. Primary identification of Microbacterium spp. encountered in clinical specimens as CDC coryneform group A-4 and A-5 bacteria. J. Clin. Microbiol. 33:188-192.[Abstract]
7
7. Funke, G., R. Frodl, and H. Sommer. 2004. First comprehensively documented case of Paracoccus yeei infection in a human. J. Clin. Microbiol. 42:3366-3368.[Abstract/Free Full Text]
8
8. Funke, G., R. Hutson, K. A. Bernard, G. E. Pfyffer, G. Wauters, and M. D. Collins. 1996. Isolation of Arthrobacter spp. from clinical specimens and description of Arthrobacter cumminsii sp. nov. and Arthrobacter woluwensis sp. nov. J. Clin. Microbiol. 34:2356-2363.[Abstract]
9
9. Funke, G., G. Martinetti Lucchini, G. E. Pfyffer, M. Marchiani, and A. von Graevenitz. 1993. Characteristics of CDC group 1 and group 1-like coryneform bacteria isolated from clinical specimens. J. Clin. Microbiol. 31:2907-2912.[Abstract/Free Full Text]
10
10. Funke, G., C. Pascual Ramos, and M. D. Collins. 1995. Identification of some clinical strains of CDC coryneform group A-3 and A-4 bacteria as Cellulomonas species and proposal of Cellulomonas hominis sp. nov. for some group A-3 strains. J. Clin. Microbiol. 33:2091-2097.[Abstract]
11
11. Funke, G., K. Peters, and M. Aravena-Roman. 1998. Evaluation of the RapID CB Plus system for identification of coryneform bacteria and Listeria spp. J. Clin. Microbiol. 36:2439-2442.[Abstract/Free Full Text]
12
12. Funke, G., F. N. R. Renaud, J. Freney, and P. Riegel. 1997. Multicenter evaluation of the updated and extended API (RAPID) Coryne data base 2.0. J. Clin. Microbiol. 35:3122-3126.[Abstract]
13
13. Funke, G., A. von Graevenitz, and N. Weiss. 1994. Primary identification of Aureobacterium spp. isolated from clinical specimens as "Corynebacterium aquaticum." J. Clin. Microbiol. 32:2686-2691.[Abstract/Free Full Text]
14
14. Komagta, K., and K. I. Suzuki. 1986. Genus Curtobacterium, p. 1313-1317. In P. H. A. Sneath, N. S. Mair, M. E. Sharpe, and J. G. Holt (ed.), Bergey's manual of systematic bacteriology, vol. 2. The Williams & Wilkins Co., Baltimore, Md.
15
15. Nash, P., and M. M. Krenz. 1991. Culture media, p. 1226-1288. In A. Balows, W. J. Hausler, Jr., K. L. Hermann, H. D. Isenberg, and H. J. Shadomy (ed.), Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
16
16. Schleifer, K. H., and O. Kandler. 1972. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol. Rev. 36:407-477.[Free Full Text]
17
17. Suzuki, K., K. Saito, A. Kawaguchi, S. Okuda, and K. Komagata. 1981. Occurrence of -cyclohexyl fatty acids in Curtobacterium pusillum strains. J. Gen. Appl. Microbiol. 27:261-266.
18
18. Uchida, K., and K. Aida. 1984. An improved method for the glycolate test for simple identification of the acyl type of bacterial cell walls. J. Gen. Appl. Microbiol. 30:131-134.
19
19. von Graevenitz, A., G. Osterhout, and J. Dick. 1991. Grouping of some clinically relevant gram-positive rods by automated fatty acid analysis. APMIS 99:147-154.[Medline]
20
20. Wisotzkey, J. D., P. Jurtshuk, Jr., G. E. Fox, G. Deinhard, and K. Poralla. 1992. Comparative sequence analyses on the 16S rRNA (rDNA) of Bacillus acidocaldarius, Bacillus acidoterrestris, and Bacillus cycloheptanicus and proposal for creation of a new genus, Alicyclobacillus gen. nov. Int. J. Syst. Bacteriol. 42:263-269.[Abstract/Free Full Text]

---

Journal of Clinical Microbiology, March 2005, p. 1032-1036, Vol. 43, No. 3
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.3.1032-1036.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Funke, G. Articles by Frodl, R. Search for Related Content PubMed PubMed Citation Articles by Funke, G. Articles by Frodl, R.